Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $-0.04221 EPS, expectations were $0.55.
Integra Lifesciences Holdings Corp (IART)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 103,215,000 | $98,735,469 | 1.71% | ||
| 2. | Deerfield Management James E. Flynn | 1,473,090 | $52,221,041 | +31% | 0.9% |
| 3. | 50,513,000 | $48,402,567 | -7% | 1.77% | |
| 4. | 27,000,000 | $25,872,795 | 0.01% | ||
| 5. | 25,000,000 | $23,926,128 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.49 | 52,641 | Officer, Director | 487,922 | 2024-05-23 | Filing | |
| $27.40 | 36,350 | Director | 36,350 | 2024-05-21 | Filing | |
| $37.89 | 2,640 | Officer | 48,597 | 2023-06-01 | Filing | |
| $38.50 | 7,792 | Officer, Director | 12,798 | 2023-06-01 | Filing | |
| $56.08 | 1,933 | Director | 3,665 | 2019-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.59 | 8,348 | Officer | 49,893 | 2024-03-06 | Filing | |
| $44.46 | 1,177 | Officer | 23,458 | 2023-08-09 | Filing | |
| $54.29 | 1,843 | Officer | 28,796 | 2023-03-07 | Filing | |
| $55.21 | 1,566 | Officer | 45,920 | 2023-03-01 | Filing | |
| $57.00 | 3,767 | Officer | 18,605 | 2023-02-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,012,793 | $305,407,135 | 0% | |
| 2. | 6,641,845 | $289,252,352 | 0% | |
| 3. | 5,270,697 | $229,538,956 | 0.02% | |
| 4. | 4,297,326 | $187,148,547 | 0.04% | |
| 5. | 3,185,293 | $138,719,511 | 0.02% |
News See All
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences’ Third Quarter 2023 Financial Results Conference Call.
15 Worst Performing Healthcare Stocks in 2023
In this article, we discuss 15 worst performing healthcare stocks in 2023.
18 Highest Paying Countries for Neurosurgeons
In this article, we will look at the 18 highest paying countries for neurosurgeons. We have also discussed key global companies which are making strides in the neurosurgery industry.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences Second Quarter 2023 Financial Results.
5 Stocks Insiders and Billionaires Are Crazy About
In this article, we will take a look at the 5 stocks insiders and billionaires are crazy about.
Hedge Fund and Insider Trading News: Boaz Weinstein, Tom Wagner, Ray Dalio, Ken Griffin, Stanley Druckenmiller, LHG Capital Management, Loews Corp (L), Align Technology, Inc. (ALGN), and More
Boaz Weinstein is taking on the world’s largest asset manager in a proxy battle.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences First Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode.
Billionaire Hedge Funds
